
For decades, the United States led the charge in the pursuit of brain-computer interface technology, betting big on bold, high-risk breakthroughs that promised to revolutionise medicine and human-machine integration.
In the end, it is China crossing the finish line first.
Advertisement
After decades of this technology being stuck in clinical trials globally, this feat makes their Neural Electronic Opportunity (Neo) implant the first invasive device in the world to be available outside trials.
Advertisement
The development of BCI has been defined by a difficult trade-off: a non-invasive approach that sacrifices precision or an invasive approach that sacrifices safety.

Don't Miss:
-
US revokes temporary sanctions waiver on Iranian oil after vessels attacked in Hormuz
-
Ten Chapitos Gunmen Killed in Government Operations in Rosario, Sinaloa
-
Colombia’s president-elect suspends transition after outgoing leader Petro’s fraud claims
-
Cardinal in Morocco steps back from duties after sexual assault claims
-
Trump still ‘disappointed’ with Nato, says US should control Greenland as summit kicks off

Taiwanese authorities charge executives who helped China’s cyber spies target ICIJ network
Who Killed Father Diệp — and Who Gets to Decide?
Duterte Impeachment Puts 2028 Race — and Philippine Institutions — on Trial